分子马达KIF1A的研究进展

驱动蛋白家族成员1A(kinesin family member 1A,KIF1A)属于向微管正向端移动的驱动蛋白第三家族,它能够利用三磷酸腺苷(adenosine triphosphate,ATP)水解释放的能量实现沿微管定向运动。KIF1A是轴突末端的突触囊泡体沿微管输运的重要载体,其马达结构域的突变将导致多种与神经有关的疾病和缺陷。文中主要综述了近年来KIF1A有关的生命过程和疾病的研究进展,介绍了KIF1A催化ATP水解反应的各中间态结构,同时基于这些结构信息,阐述了KIF1A的运动形式、核苷酸轮换机制和运动机理,并对今后的研究前景进行了展望,旨为KIF1A相关研究提供思路。     

急性缺氧和急性低糖对脑片tau蛋白磷酸化的影响

为探讨急性缺氧对tau蛋白磷酸化的影响,将Wistar大鼠脑片进行不同时间的缺氧培养后,对tau蛋白的磷酸化状态及相关磷酸酯酶的活性和表达进行检测.结果显示,急性缺氧使tau蛋白多个丝氨酸位点磷酸化水平下降,蛋白磷酸酯酶～2A(PP-2A)的活性升高,其催化亚单位表达上调,而蛋白磷酸酯酶-1(PP-1)的活性及催化亚单位表达均无明显改变.该研究结果表明:急性缺氧可能通过蛋白磷酸酯酶-2A的上调而使tau蛋白多个丝氨酸位点发生去磷酸化作用.     

微管解聚酶驱动蛋白家族成员KIF2A研究进展

驱动蛋白家族成员2A(KIF2A)是一种能够与微管相互作用的蛋白,它参与了细胞内物质运输、细胞迁移、细胞形态改变,以及有丝分裂细胞纺锤体动力学等重要的细胞活动。近年来研究发现,KIF2A凭借其独特的微管解聚能力,对神经元中神经突的生长以及细胞有丝分裂中染色体的运动起着重要的调节作用。将主要对KIF2A在脊椎动物神经元发育和细胞有丝分裂中所行使的作用和功能进行综述。     

玉米根V-ATPase的A亚基磷酸化位点的鉴定

以玉米(Zea mays L)根的高纯度液泡膜为材料进行的磷酸化反应表明,液泡膜蛋白的磷酸化可明显提高v型H -ATPase(V-ATPase)的ATP水解活性和H 转运活性.进一步研究表明,纯化的液泡膜蛋白能被硫代磷酸化,用V-ATPase的A亚基抗体将一条约69 kD的条带鉴定为A亚基.为了测定V-ATPase的A亚基的磷酸化位点,从硫代磷酸化的凝胶中切下A亚基条带并用胰蛋白酶彻底消化.用RP-HPLC分离纯化酶解片断,收集纯化的硫代磷酸化肽段进行质谱分析所测定的分子量为573.83 Da.A亚基胰蛋白酶彻底消化后能产生61个肽段,只有F56肽段的分子量573.66 Da与573.83 Da最接近,而且F56肽段上只有第525位的丝氨酸可以被磷酸化.因此可以确定,玉米根V-AT-Pase A亚基的潜在磷酸化位点为Ser525.就我们所知,这是首次确定植物V-ATPase A亚基的磷酸化位点.     

糖尿病大鼠脑细胞周期依赖性蛋白激酶5和蛋白激酶A参与调节Tau蛋白磷酸化

细胞周期依赖性蛋白激酶5(cyclin-dependent kinase5,Cdk-5)及蛋白激酶A(protein kinaseA,PKA)是调节Tau蛋白磷酸化的重要激酶,其对糖尿病(diabetes mellitus,DM)大鼠脑内Tau蛋白磷酸化的作用如何,目前尚不明确.为探讨胰岛素缺乏的DM大鼠海马Cdk-5及PKA对Tau蛋白磷酸化的作用,用链脲佐菌素(streptozotocin,STZ)建立DM大鼠模型,Fura-2负载及荧光测定细胞内游离Ca2 浓度,免疫沉淀法测定Cdk-5活性,放射性配体结合实验检测PKA的活性,蛋白质印迹检测Tau蛋白磷酸化的水平.结果提示:在DM大鼠海马神经元,Ca2 浓度升高,Cdk-5及PKA活性升高,Tau蛋白在Ser198/Ser199/Ser202和Ser396/Ser404位点的磷酸化增强.Cdk-5的特异性抑制剂roscovitine可降低DM大鼠Cdk-5活性,但不能降低PKA活性,使Tau蛋白在Ser198/Ser199/Ser202位点磷酸化水平降低,但不降低Ser396/Ser404位点的磷酸化,roscovitine处理正常大鼠后,上述酶的活性及Tau蛋白的磷酸化无明显变化.首次从整体水平上证实DM大鼠海马Cdk-5及PKA活性升高,协同促进Tau蛋白在Ser198/Ser199/Ser202位点和Ser396/Ser404位点的磷酸化,神经元内游离Ca2 浓度升高可能起重要作用.     

反复饥饿对大鼠空间学习及海马神经元骨架蛋白磷酸化的影响

为了进一步研究饥饿处理对大鼠空间学习、记忆的影响,通过饥饿2 d、恢复喂食3 d的方法,连续60 d,用Morris水迷宫检测大鼠的空间学习能力.免疫印迹检测神经元骨架蛋白—tau蛋白和神经细丝(Neurofilament,NF)磷酸化水平与分布变化,以及骨架蛋白磷酸化调节的关键酯酶磷酸酯酶PP-2A催化亚单位蛋白水平与分布.反复饥饿的大鼠空间学习能力明显差于对照组(P0.05),tau蛋白在Ser199/202位点和Ser396/404位点发生了过度磷酸化(P0.05),NF磷酸化水平无明显改变,PP-2A的催化亚单位蛋白水平下调(P0.05).反复饥饿可以引起大鼠出现空间学习记忆障碍,下调PP-2A催化亚单位蛋白水平,PP-2A活性抑制及tau蛋白发生过度磷酸化.     

dbcAMP通过Cdc25B蛋白调控小鼠1-细胞期受精卵发育

为了研究PKA激活剂dbcAMP通过调控小鼠Cdc25B蛋白S149和S321位点磷酸化状态影响 小鼠1-细胞期受精卵的发育,将质粒pBSK-Cdc25B-WT、pBSK-Cdc25B-S149A、pBSK- Cdc25B-S321A和pBSK-Cdc25B-S149A/S321A体外转录成mRNA;显微注射入S期受精卵中 ,在2 mmol/L dbcAMP的M16培养基中培养,观察其对受精卵发育、MPF活性及CDC2- pTyr15磷酸化状态的影响. 结果显示,在有dbcAMP存在时,各组受精卵卵裂时间延迟 ,但Cdc25B-S/A mRNAs注射组受精卵卵裂率明显高于Cdc25B-WT mRNA注射组,MPF 活性提前达到高峰;CDC2-pTyr15磷酸化状态和MPF活性变化相一致. 因此,在小鼠1- 细胞期受精卵有丝分裂过程中,PKA对小鼠Cdc25B蛋白S149位点与S321位点的磷酸化 修饰是控制受精卵G2/M转换的重要方式.     

蛋白磷酸酯酶2A调节微管相关蛋白1b的磷酸化

微管相关蛋白MAP1b的生物学活性受其磷酸化修饰的调节,后者则受相应的蛋白激酶和蛋白磷酸酯酶(PP)调控.为研究蛋白磷酸酯酶在脑内对MAP1b磷酸化的调控作用,采用有代谢活性的大鼠脑片作为模型,分别应用冈田酸(okadaic acid)和cyclosporin A选择性地抑制PP2A 和PP2B活性,来研究其对脑内蛋白磷酸酯酶MAP1b磷酸化的调控.采用特异性的MAP1bⅠ型磷酸化依赖性抗体522和免疫印迹技术检测MAP1bⅠ型磷酸化.结果表明,当PP2A被okadaic acid选择性抑制后,MAP1bⅠ型磷酸化明显增加.而PP2B被选择性地抑制后,MAP1b磷酸化的变化不大.免疫组化染色显示,MAP1b广泛分布于鼠大脑神经元和突起中,与对照组相比,在PP2A抑制的脑片中抗体522的免疫活性在神经元中明显升高.上述结果表明,PP2A是脑中调控MAP1bⅠ型磷酸化的主要蛋白磷酸酯酶.     

糖尿病大鼠脑GSK-3与PP-2A失调诱导tau蛋白过度磷酸化

探讨胰岛素缺乏的糖尿病大鼠皮层糖原合酶激酶-3(GSK-3)及蛋白磷酯酶-2A(PP-2A)变化及其对tau蛋白磷酸化的作用.用链脲佐菌素(streptozotocin,STZ)建立胰岛素缺乏的糖尿病大鼠模型,用放射性配体结合实验检测了GSK-3和PP-2A的活性,蛋白质印迹检测了tau蛋白的磷酸化水平及PP-2A的表达.结果提示:在糖尿病大鼠皮层,GSK-3活性升高,PP-2A活性及表达降低,tau蛋白在Ser198/Ser199/Ser202和Ser396/Ser404位点磷酸化.应用GSK-3的选择性抑制剂Li2CO3后,GSK-3活性降低,PP-2A活性及表达恢复,tau蛋白在Ser198/Ser199/Ser202和Ser396/Ser404位点磷酸化水平降低.研究提示:糖尿病大鼠皮层GSK-3升高可能抑制PP-2A的活性,升高的GSK-3和降低的PP-2A协同促进tau蛋白的磷酸化.     

KIF26B在非小细胞肺癌发生发展过程中的表达与功能研究

驱动蛋白与肿瘤的发生有密切联系，但对 KIF26B驱动蛋白在非小细胞肺癌的表达和相关功能作用的研究甚少。为了探索KIF26B在非小细胞肺癌中的表达水平及潜在机制，通过干扰KIF26B后探索对非小细胞肺癌增殖、侵袭、迁移、细胞周期、凋亡以及相关蛋白表达量的影响。对mRNA TCGA 数据库信息分析得出，KIF26B基因在非小细胞肺癌中高表达。qRT-PCR 检测 KIF26B在几株常见非小细胞肺癌细胞系中的表达水平，筛选出 KIF26B在A549 和 NCI-H292细胞系中高表达。利用 RNA干扰技术(RNA interference, RNAi)敲低 A549 和 NCI-H292细胞的 KIF26B基因，通过CCK8、采用实时细胞分析仪、平板克隆及 Transwell 实验检测敲低 KIF26B基因后的生物学功能，免疫印迹法检测蛋白表达水平。结果显示，敲低KIF26B后A549 和 NCI-H292细胞增殖明显降低，侵袭及迁移能力明显减弱。敲低KIF26B后阻碍了A549 和 NCI-H292细胞从G1期向S期的转变，同时凋亡细胞明显增多，与之相关的细胞周期蛋白 D1、Bcl-2、E-cadherin和Vimentin的表达水平显著下调，同时活化的半胱天冬酶-3（active Caspase-3）和其剪切底物 PARP1 的剪切体（cleaved PARP1）表达水平显著上调。结果表明KIF26B可能作为非小细胞肺癌发生的促癌基因，参与了非小细胞肺癌的发生及发展过程。KIF26B有望成为非小细胞肺癌治疗的潜在靶点。     

The CC1-FHA Tandem as a Central Hub for Controlling the Dimerization and Activation of Kinesin-3 KIF1A

Kinesin-3 KIF1A plays prominent roles in axonal transport and synaptogenesis. KIF1A adopts?a monomeric form in?vitro but acts as a processive dimer in?vivo. The mechanism underlying the motor dimerization is poorly understood. Here, we find that the CC1-FHA tandem of KIF1A exists as a stable dimer. The structure of CC1-FHA reveals that the linker between CC1 and FHA unexpectedly forms a β-finger hairpin, which integrates CC1 with FHA assembling a CC1-FHA homodimer. More importantly, dissociation of the CC1-FHA dimer unleashes CC1 and the β-finger, which are both essential for the motor inhibition. Thus, dimerization of the CC1-FHA tandem not only promotes the KIF1A dimer formation but also may trigger the motor activity via sequestering the CC1/β-finger region. The CC1-FHA tandem likely functions as a hub for controlling the dimerization and activation of KIF1A, which may represent?a new paradigm for the kinesin regulation shared by other kinesin-3 motors.     

Structural Correlation of the Neck Coil with the Coiled-coil (CC1)-Forkhead-associated (FHA) Tandem for Active Kinesin-3 KIF13A

Processive kinesin motors often contain a coiled-coil neck that controls the directionality and processivity. However, the neck coil (NC) of kinesin-3 is too short to form a stable coiled-coil dimer. Here, we found that the coiled-coil (CC1)-forkhead-associated (FHA) tandem (that is connected to NC by Pro-390) of kinesin-3 KIF13A assembles as an extended dimer. With the removal of Pro-390, the NC-CC1 tandem of KIF13A unexpectedly forms a continuous coiled-coil dimer that can be well aligned into the CC1-FHA dimer. The reverse introduction of Pro-390 breaks the NC-CC1 coiled-coil dimer but provides the intrinsic flexibility to couple NC with the CC1-FHA tandem. Mutations of either NC, CC1, or the FHA domain all significantly impaired the motor activity. Thus, the three elements within the NC-CC1-FHA tandem of KIF13A are structurally interrelated to form a stable dimer for activating the motor. This work also provides the first direct structural evidence to support the formation of a coiled-coil neck by the short characteristic neck domain of kinesin-3.     

Fast or Slow,Either Head Can Start the Processive Run of Kinesin-2 KIF3AC

Mammalian KIF3AC contains two distinct motor polypeptides and is best known for its role in organelle transport in neurons. Our recent studies showed that KIF3AC is as processive as conventional kinesin-1, suggesting that their ATPase mechanochemistry may be similar. However, the presence of two different motor polypeptides in KIF3AC implies that there must be a cellular advantage for the KIF3AC heterodimer. The hypothesis tested was whether there is an intrinsic bias within KIF3AC such that either KIF3A or KIF3C initiates the processive run. To pursue these experiments, a mechanistic approach was used to compare the pre-steady-state kinetics of KIF3AC to the kinetics of homodimeric KIF3AA and KIF3CC. The results indicate that microtubule collision at 11.4 μm⁻¹ s⁻¹ coupled with ADP release at 78 s⁻¹ are fast steps for homodimeric KIF3AA. In contrast, KIF3CC exhibits much slower microtubule association at 2.1 μm⁻¹ s⁻¹ and ADP release at 8 s⁻¹. For KIF3AC, microtubule association at 6.6 μm⁻¹ s⁻¹ and ADP release at 51 s⁻¹ are intermediate between the constants for KIF3AA and KIF3CC. These results indicate that either KIF3A or KIF3C can initiate the processive run. Surprisingly, the kinetics of the initial event of microtubule collision followed by ADP release for KIF3AC is not equivalent to 1:1 mixtures of KIF3AA plus KIF3CC homodimers at the same motor concentration. These results reveal that the intermolecular communication within the KIF3AC heterodimer modulates entry into the processive run regardless of whether the run is initiated by the KIF3A or KIF3C motor domain.     

Motor domain-mediated autoinhibition dictates axonal transport by the kinesin UNC-104/KIF1A

The UNC-104/KIF1A motor is crucial for axonal transport of synaptic vesicles, but how the UNC-104/KIF1A motor is activated in vivo is not fully understood. Here, we identified point mutations located in the motor domain or the inhibitory CC1 domain, which resulted in gain-of-function alleles of unc-104 that exhibit hyperactive axonal transport and abnormal accumulation of synaptic vesicles. In contrast to the cell body localization of wild type motor, the mutant motors accumulate on neuronal processes. Once on the neuronal process, the mutant motors display dynamic movement similarly to wild type motors. The gain-of-function mutation on the motor domain leads to an active dimeric conformation, releasing the inhibitory CC1 region from the motor domain. Genetically engineered mutations in the motor domain or CC1 of UNC-104, which disrupt the autoinhibitory interface, also led to the gain of function and hyperactivation of axonal transport. Thus, the CC1/motor domain-mediated autoinhibition is crucial for UNC-104/KIF1A-mediated axonal transport in vivo.     

Specific KIF1A–adaptor interactions control selective cargo recognition

Intracellular transport in neurons is driven by molecular motors that carry many different cargos along cytoskeletal tracks in axons and dendrites. Identifying how motors interact with specific types of transport vesicles has been challenging. Here, we use engineered motors and cargo adaptors to systematically investigate the selectivity and regulation of kinesin-3 family member KIF1A–driven transport of dense core vesicles (DCVs), lysosomes, and synaptic vesicles (SVs). We dissect the role of KIF1A domains in motor activity and show that CC1 regulates autoinhibition, CC2 regulates motor dimerization, and CC3 and PH mediate cargo binding. Furthermore, we identify that phosphorylation of KIF1A is critical for binding to vesicles. Cargo specificity is achieved by specific KIF1A adaptors; MADD/Rab3GEP links KIF1A to SVs, and Arf-like GTPase Arl8A mediates interactions with DCVs and lysosomes. We propose a model where motor dimerization, posttranslational modifications, and specific adaptors regulate selective KIF1A cargo trafficking.     

KIF1A mediates axonal transport of BACE1 and identification of independently moving cargoes in living SCG neurons

Neurons rely heavily on axonal transport to deliver materials from the sites of synthesis to the axon terminals over distances that can be many centimetres long. KIF1A is the neuron‐specific kinesin with the fastest reported anterograde motor activity. Previous studies have shown that KIF1A transports a subset of synaptic proteins, neurofilaments and dense‐core vesicles. Using two‐colour live imaging, we showed that beta‐secretase 1 (BACE1)‐mCherry moves together with KIF1A‐GFP in both the anterograde and retrograde directions in superior cervical ganglions (SCG) neurons. We confirmed that KIF1A is functionally required for BACE1 transport by using KIF1A siRNA and a KIF1A mutant construct (KIF1A‐T312M) to impair its motor activity. We further identified several cargoes that have little or no co‐migration with KIF1A‐GFP and also move independently from BACE1‐mCherry. Together, these findings support a primary role for KIF1A in the anterograde transport of BACE1 and suggest that axonally transported cargoes are sorted into different classes of carrier vesicles in the cell body and are transported by cargo‐specific motor proteins through the axon.      

Dimerization Mediated by a Divergent Forkhead-associated Domain Is Essential for the DNA Damage and Spindle Functions of Fission Yeast Mdb1

MDC1 is a key factor of DNA damage response in mammalian cells. It possesses two phospho-binding domains. In its C terminus, a tandem BRCA1 C-terminal domain binds phosphorylated histone H2AX, and in its N terminus, a forkhead-associated (FHA) domain mediates a phosphorylation-enhanced homodimerization. The FHA domain of the Drosophila homolog of MDC1, MU2, also forms a homodimer but utilizes a different dimer interface. The functional importance of the dimerization of MDC1 family proteins is uncertain. In the fission yeast Schizosaccharomyces pombe, a protein sharing homology with MDC1 in the tandem BRCA1 C-terminal domain, Mdb1, regulates DNA damage response and mitotic spindle functions. Here, we report the crystal structure of the N-terminal 91 amino acids of Mdb1. Despite a lack of obvious sequence conservation to the FHA domain of MDC1, this region of Mdb1 adopts an FHA-like fold and is therefore termed Mdb1-FHA. Unlike canonical FHA domains, Mdb1-FHA lacks all the conserved phospho-binding residues. It forms a stable homodimer through an interface distinct from those of MDC1 and MU2. Mdb1-FHA is important for the localization of Mdb1 to DNA damage sites and the spindle midzone, contributes to the roles of Mdb1 in cellular responses to genotoxins and an antimicrotubule drug, and promotes in vitro binding of Mdb1 to a phospho-H2A peptide. The defects caused by the loss of Mdb1-FHA can be rescued by fusion with either of two heterologous dimerization domains, suggesting that the main function of Mdb1-FHA is mediating dimerization. Our data support that FHA-mediated dimerization is conserved for MDC1 family proteins.     

Expression of Bacillus sp. β-xylosidase gene (xylB) in Saccharomyces cerevisiae

-Xylosidase gene (xylB) from Bacillus sp. was amplified and inserted between GAL10 promoter and GAL7 terminator. For the secretory production of xylB in Saccharomyces cerevisiae, in-frame fusion of the exoinulinase signal sequence (INU1s) of Kluyveromyces marxianus to the upstream of xylB was conducted. When a transformant of S. cerevisiae harboring the resulting plasmid was grown on galactose-containing medium, most of -xylosidase activity was localized in the periplasmic space of yeast and a maximum total activity reached about 2.9 unit ml^–1 at 42 h cultivation. The recombinant -xylosidase was produced as an active dimer form.     

Human kidney anion exchanger 1 interacts with kinesin family member 3B (KIF3B)

Impaired trafficking of human kidney anion exchanger 1 (kAE1) to the basolateral membrane of α-intercalated cells of the kidney collecting duct leads to the defect of the Cl⁻/ exchange and the failure of proton (H⁺) secretion at the apical membrane of these cells, causing distal renal tubular acidosis (dRTA). In the sorting process, kAE1 interacts with AP-1 mu1A, a subunit of AP-1A adaptor complex. However, it is not known whether kAE1 interacts with motor proteins in its trafficking process to the plasma membrane or not. We report here that kAE1 interacts with kinesin family member 3B (KIF3B) in kidney cells and a dileucine motif at the carboxyl terminus of kAE1 contributes to this interaction. We have also demonstrated that kAE1 co-localizes with KIF3B in human kidney tissues and the suppression of endogenous KIF3B in HEK293T cells by small interfering RNA (siRNA) decreases membrane localization of kAE1 but increases its intracellular accumulation. All results suggest that KIF3B is involved in the trafficking of kAE1 to the plasma membrane of human kidney α-intercalated cells.